Understanding Hypertrophic Cardiomyopathy: From Disease Mechanisms to Clinical Management - Episode 2
Panelists discuss the signs, symptoms, diagnostic delays, and classification of obstructive hypertrophic cardiomyopathy, including how it differs from other forms and its implications for clinical management.
In this episode, Recognizing and Classifying Obstructive Hypertrophic Cardiomyopathy, the cardiology experts explore the following questions:
What are the signs and symptoms of obstructive hypertrophic cardiomyopathy and how long does it usually take to arrive at a diagnosis?
Let’s get into the classification of obstructive hypertrophic cardiomyopathy. Can you please describe it compared with other types?
The panelists examined obstructive hypertrophic cardiomyopathy (oHCM), which commonly presents with symptoms such as dyspnea, chest pain, fatigue, syncope, and palpitations, though these can be nonspecific and contribute to delays in recognition. As a result, it may take several years from symptom onset to arrive at an accurate diagnosis, particularly in patients without a known family history. oHCM is characterized by left ventricular outflow tract obstruction, which distinguishes it from non-obstructive forms of hypertrophic cardiomyopathy that lack significant hemodynamic obstruction. Classification of HCM broadly includes obstructive, non-obstructive, and latent forms, each with different clinical implications and management strategies.
Throughout the conversation, the experts provide a comprehensive reflection on the field and the factors that may shape how clinicians approach care moving forward.
The next episode in this series, The Importance of Early Diagnosis and Treatment in Obstructive HCM, features the panelists advancing their conversation on the critical role of early diagnosis in obstructive hypertrophic cardiomyopathy, emphasizing the value of thorough history taking in identifying symptoms and familial risk. It also reviews current treatment recommendations aimed at managing symptoms, reducing obstruction, and improving long-term patient outcomes.